PDCD1 and neoplasm: Targeting the immune checkpoint molecules cytotoxic T-lymphocyte antigen 4, programmed cell death protein 1 (PD-1), or programmed death-ligand 1 (PD-L1) represents an attractive treatment for tumor patients.1